Related Experiment Video
Updated: Aug 24, 2026

Improved Enzyme Protection Assay to Study Staphylococcus aureus Internalization and Intracellular Efficacy of Antimicrobial Compounds
Published on: September 8, 2021
Structural differences between paroxetine and femoxetine responsible for differential inhibition of Staphylococcus
Peng Wei1, Glenn W Kaatz, Robert J Kerns
1Division of Medicinal and Natural Products Chemistry, The University of Iowa, Iowa City, IA 52242, USA.
Abstract:
In this study the chemical modification of paroxetine was employed to determine which structural differences between the paroxetine-like and femoxetine-like selective serotonin reuptake inhibitors is responsible for the differential potency of these agents in the inhibition of Staphylococcus aureus multidrug efflux pump systems.
Related Concept Videos
Nonlinear Pharmacokinetics: Dependence of Elimination Half-Life and Dose Clearance
A study on guinea pigs examined the...
Mechanism of Antibiotic Resistance in MRSA
Clinical Significance of Antibiotic Resistance
Combined Effects of Drugs: Synergism
Such synergistic combinations...
Factors Affecting Dissolution: Drug Permeability, Stability and Stereochemistry
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence